SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-003466
Filing Date
2017-03-06
Accepted
2017-03-06 16:05:01
Documents
82
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AKBA-10K-20161231 akba-10k_20161231.htm 10-K 3454820
2 EX-10.26 akba-ex1026_696.htm EX-10.26 1220641
3 EX-21.1 akba-ex211_7.htm EX-21.1 12059
4 EX-23.1 akba-ex231_9.htm EX-23.1 6055
5 EX-31.1 akba-ex311_12.htm EX-31.1 17570
6 EX-31.2 akba-ex312_11.htm EX-31.2 17568
7 EX-32.1 akba-ex321_6.htm EX-32.1 12077
8 EX-99.1 akba-ex991_10.htm EX-99.1 123131
9 GRAPHIC g2017030617075645022502.jpg GRAPHIC 13708
10 GRAPHIC g2017030617080648522505.jpg GRAPHIC 48693
11 GRAPHIC g2017030617075646022503.jpg GRAPHIC 37733
12 GRAPHIC g2017030617075662922504.jpg GRAPHIC 30006
13 GRAPHIC g2017030617074414926771.jpg GRAPHIC 2066
  Complete submission text file 0001564590-17-003466.txt   13192219

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE DOCUMENT akba-20161231.xml EX-101.INS 2650900
15 XBRL TAXONOMY EXTENSION SCHEMA akba-20161231.xsd EX-101.SCH 65176
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20161231_cal.xml EX-101.CAL 70493
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20161231_def.xml EX-101.DEF 247891
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20161231_lab.xml EX-101.LAB 558207
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20161231_pre.xml EX-101.PRE 446926
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36352 | Film No.: 17667882
SIC: 2834 Pharmaceutical Preparations